Cargando…

Role of monocyte chemoattractant protein‐1 in liver fibrosis with transient myeloproliferative disorder in down syndrome

Liver fibrosis is a common complication associated with transient myeloproliferative disorder (TMD) in Down syndrome (DS). The exact molecular pathogenesis that regulates disease progression is largely unknown. We recently found serum and/or urinary monocyte chemoattractant protein‐1 (MCP‐1) as a no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Kenichiro, Yoshioka, Takako, Miyauchi, Jun, Nakazawa, Atsuko, Kiyokawa, Nobutaka, Maihara, Toshiro, Usami, Ikuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831021/ https://www.ncbi.nlm.nih.gov/pubmed/29507898 http://dx.doi.org/10.1002/hep4.1150

Ejemplares similares

Hematological manifestation of scurvy
por: Kobayashi, Kenichiro, et al.
Publicado: (2023)

Establishment of multiplex RT-PCR to detect fusion genes for the diagnosis of Ewing sarcoma
por: Ueno-Yokohata, Hitomi, et al.
Publicado: (2021)

Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)

Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction
por: Morimoto, Hajime, et al.
Publicado: (2007)

Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice
por: Lu, Bao, et al.
Publicado: (1998)

Monocyte chemoattractant protein-1 in patients with peripheral arterial disease.
por: Petrkova, Jana, et al.
Publicado: (2004)

Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022)

Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients
por: Hefler, L, et al.
Publicado: (1999)

Chemoattractant-induced activation of c-fos gene expression in human monocytes
Publicado: (1987)

Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1
por: Mitchell, Ryan M, et al.
Publicado: (2009)

The Potential Role of Monocyte Chemoattractant Protein-1 for Major Depressive Disorder
por: Pae, Chi-Un
Publicado: (2014)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
Publicado: (1989)

Monocyte chemoattractant protein-1 promoter polymorphism and plasma levels in alzheimer’s disease
por: Porcellini, Elisa, et al.
Publicado: (2013)

Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis
por: Radhakrishnan, Preethi, et al.
Publicado: (2014)

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
por: Lim, Jun Pei, et al.
Publicado: (2015)

Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
por: Wyler, Stephanie L., et al.
Publicado: (2016)

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1β and G-CSF after Transient Focal Ischemia in Mice
por: Strecker, Jan-Kolja, et al.
Publicado: (2011)

L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels
por: Chen, Liang, et al.
Publicado: (2017)

Phenotypic switching to hypereosinophilia during cytoreductive therapy for transient abnormal myelopoiesis associated with Down syndrome
por: Kobayashi, Kenichiro, et al.
Publicado: (2022)

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis
por: Dunaeva, Marina, et al.
Publicado: (2009)

Characterisation of urinary monocyte chemoattractant protein 1: Potential biomarker for patients with overactive bladder
por: Farhan, Bilal, et al.
Publicado: (2019)

Monocyte chemoattractant protein 1 expression and proliferation in primary central nervous system lymphoma
por: Takahashi, Yoshinobu, et al.
Publicado: (2017)

Transient myeloproliferative disorder as the presenting feature for mosaic trisomy 21
por: Baca, Nicole, et al.
Publicado: (2021)

Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report
por: Tragiannidis, Athanasios, et al.
Publicado: (2011)

Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells
por: Godiska, Ronald, et al.
Publicado: (1997)

Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
por: Ohlsson, Sophie, et al.
Publicado: (2009)

Analysis of the Monocyte Chemoattractant Protein 1 -2518 Promoter Polymorphism in Korean Patients with Alopecia Areata
por: Hong, Seok-Beom, et al.
Publicado: (2006)

PARK2 Mediates Interleukin 6 and Monocyte Chemoattractant Protein 1 Production by Human Macrophages
por: de Léséleuc, Louis, et al.
Publicado: (2013)

Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm
por: Wang, Qiwei, et al.
Publicado: (2014)

Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
por: Wang, Who-Whong, et al.
Publicado: (2013)

The therapeutic effect of monocyte chemoattractant protein-1 delivered by an electrospun scaffold for hyperglycemia and nephrotic disorders
por: Yong, Cai, et al.
Publicado: (2014)

Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Yong, Kok-Khun, et al.
Publicado: (2016)

Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis
por: Graupera, Isabel, et al.
Publicado: (2016)

Data on early postoperative changes in aqueous monocyte chemoattractant protein-1 levels after phacoemulsification
por: Kawai, Motofumi, et al.
Publicado: (2016)

Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain
por: Liu, Lei, et al.
Publicado: (2017)

Circulating Monocyte Chemoattractant Protein-1 Levels and Lumbar Bone Mineral Density in Korean Women
por: Lee, Seong-Kyu
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_038gv6td4ung86oefr0hoso6ql